2m 2m 2m 2m 2m 2m 2m
Globus Medical-A (GMED)
NYSE
$78.27-$0.92 (-1.16%)
Price as of Jun 23, 2026 4:47 PM EDT- $9.0BMarket Cap
- 36.98%1-Year Change
- Medical DevicesIndustry
Globus Medical-A (GMED)
$78.27-$0.92 (-1.16%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 2.9B +16.65% | 2.5B +60.62% | 1.6B +53.34% | 1.0B +6.76% | |
Cost of Revenue | 957.8M -7.50% | 1.0B +88.90% | 548.2M +107.86% | 263.7M +10.24% | |
Gross Profit | 2.0B +33.51% | 1.5B +45.43% | 1.0B +34.41% | 759.1M +5.60% | |
Sales and Marketing Expense | 1.2B +20.13% | 981.0M +52.48% | 643.4M +48.90% | 432.1M +5.87% | |
Research and Development Expense | -147.2M -10.08% | -163.8M +32.05% | -124.0M +69.84% | -73.0M -24.99% | |
Depreciation and Amortization Expense | 276.8M +8.98% | 254.0M +75.51% | 144.7M +112.06% | 68.3M -2.31% | |
Total Operating Expenses | 957.8M -7.50% | 1.0B +16.72% | 887.2M +67.02% | 531.2M -2.88% | |
Operating Profit | 479.8M +189.06% | 166.0M +24.67% | 133.1M -41.59% | 228.0M +32.57% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | 1.9M +219.83% | |
Interest Expense | -6.9M +65.65% | -4.2M -55.62% | -9.4M N/A | N/A N/A | |
Interest Income and Expense and Net | -6.9M +65.65% | -4.2M -55.62% | -9.4M -608.84% | 1.9M +219.83% | |
Total Nonoperating Income and Expense | 125.3M +376.68% | -45.3M -240.36% | 32.3M +114.04% | 15.1M +78.24% | |
Income before Taxes | 605.1M +401.21% | 120.7M -27.01% | 165.4M -31.94% | 243.0M +34.71% | |
Income Taxes | 67.2M +278.85% | 17.7M -58.28% | 42.5M -19.55% | 52.9M +69.30% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 537.9M +422.28% | 103.0M -16.19% | 122.9M -35.39% | 190.2M +27.47% | |
Net Income from Continuing Operations Applicable to Common | 605.1M +401.21% | 120.7M -27.01% | 165.4M -31.94% | 243.0M +34.71% | |
Basic EPS and Net Income | 3.98 +423.68% | 0.76 -30.28% | 1.09 -42.33% | 1.89 +27.70% | |
Diluted EPS and Net Income | 3.92 +422.67% | 0.75 -29.91% | 1.07 -42.16% | 1.85 +28.47% | |
Basic Weighted Average Shares | 135.2M -0.38% | 135.7M +20.02% | 113.1M +12.56% | 100.5M -0.26% | |
Diluted Weighted Average Shares | 137.1M -0.59% | 137.9M +20.27% | 114.6M +11.68% | 102.6M -0.95% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 526.2M -32.93% | 784.4M +67.87% | 467.3M +210.56% | 150.5M -22.07% | |
Short-Term Investments | 31.1M -70.57% | 105.6M +109.16% | 50.5M -82.92% | 295.6M +18.06% | |
Cash and Cash Equivalents and Short-Term Investments | 557.2M -37.39% | 890.1M +71.90% | 517.8M +16.08% | 446.1M +0.59% | |
Total Current Assets | 2.1B -2.37% | 2.2B +13.67% | 1.9B +94.78% | 983.3M +13.75% | |
Accumulated Depreciation | 705.0M +29.17% | 545.8M +28.21% | 425.7M +24.10% | 343.0M +12.26% | |
Property and Plant and Equipment and Net | 564.5M +0.45% | 561.9M -4.26% | 586.9M +140.81% | 243.7M +10.25% | |
Total Long-Term Assets | 78.8M +4.91% | 75.1M -4.45% | 78.6M +81.46% | 43.3M +19.20% | |
Total Assets | 5.3B +0.97% | 5.3B +3.26% | 5.1B +144.98% | 2.1B +6.07% | |
Income Taxes Payable | 4.2M -88.00% | 34.6M -60.78% | 88.3M +3,087.65% | 2.8M -48.34% | |
Total Short-Term Debt | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Total Current Liabilities | 498.5M -41.76% | 855.9M +118.15% | 392.3M +146.44% | 159.2M +13.58% | |
Total Long-Term Debt | 0 -100.00% | 417.4M 0.00% | 417.4M N/A | N/A N/A | |
Total Long-Term Liabilities | 21.3M -0.87% | 21.5M -12.46% | 24.6M +77.97% | 13.8M +9.32% | |
Total Liabilities | 729.5M -32.10% | 1.1B -1.26% | 1.1B +373.61% | 229.8M +6.43% | |
Retained Earnings | 1.4B +20.40% | 1.2B +1.37% | 1.1B -8.28% | 1.2B +3.82% | |
Total Stockholders Equity | 4.6B +9.48% | 4.2B +4.49% | 4.0B +116.53% | 1.8B +6.03% | |
Total Shares Outstanding | 112.6M -18.04% | 137.4M +0.80% | 136.3M +36.07% | 100.2M -1.33% | |
Cash Flow | |||||
Cash from Operating Activities | 753.4M +44.72% | 520.6M +113.82% | 243.5M +36.44% | 178.5M -35.40% | |
Capital Expenditures | 164.7M +42.67% | 115.4M +47.47% | 78.3M +5.71% | 74.0M +30.14% | |
Cash from Investing Activities | -355.0M +101.65% | -176.1M -158.11% | 303.0M +374.52% | -110.4M -70.64% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -679.2M +2,352.20% | -27.7M -88.05% | -231.8M +110.82% | -110.0M -303.08% | |
Financials Ratio | |||||
Gross Margin | 67.41% +14.45% | 58.90% -9.46% | 65.05% -12.35% | 74.22% -1.09% | |
Operating Margin | 16.33% +147.79% | 6.59% -22.38% | 8.49% -61.91% | 22.29% +24.17% | |
Return on Assets | 10.19% +411.55% | 1.99% -41.93% | 3.43% -63.61% | 9.43% +14.93% | |
Return on Equity | 12.29% +387.95% | 2.52% -40.08% | 4.20% -60.33% | 10.60% +15.39% | |
Revenue Growth | 16.65% -72.53% | 60.62% +13.65% | 53.34% +689.45% | 6.76% -68.46% | |
Current Ratio | 4.26 +67.62% | 2.54 -47.89% | 4.88 -20.96% | 6.18 +0.14% | |
Cash Ratio | 1.06 +15.17% | 0.92 -23.05% | 1.19 +26.02% | 0.95 -31.39% | |
Debt-to-Equity Ratio | 0.00 -100.00% | 0.10 -4.31% | 0.10 N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.00 -100.00% | 0.08 -3.17% | 0.08 N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow